(Q59624425)
Statements
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study (English)
Byron J Hoogwerf
Michael Nauck
Thomas Forst
Wayne H-H Sheu
Cory R Heilmann
Aijun Gao
Marilyn K Boardman
Mark Fineman
Lisa Porter
Guntram Schernthaner
7 November 2012